Combined with our findings that Cdc42 is closely related to D2R and is essential for ameliorating deficits in spine morphology and behavior performance in parkinsonian mice, it is tempting to speculate that Cdc42 is a promising therapeutic target for improving motor and cognitive deficits in Parkinson's disease. This evidence concerns the gene CDC42 and cognition.